Skip to main content
Top

Advances in Therapy

Issue 2/2025

Content (40 Articles)

Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney Care

Ricardo Correa-Rotter, Steven J. Chadban, Laura Christen, Kelli Collins Damron, Lweendo Hamusankwa, Sarah Jarvis, Surendra Pentakota, Marisol Robles, Petrina Stevens, Christoph Wanner

An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases

  • Open Access
  • Commentary

Min Yang, Manish Mittal, A. Mark Fendrick, Diana Brixner, Bruce W. Sherman, Yifei Liu, Pankaj Patel, Jerry Clewell, Qing Liu, Louis P. Garrison Jr.

Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review

Khashayar Azimpour, Carla Tordoff-Gibson, Patricia Dorling, Irene Koulinska, Swati Kunduri, Victor Laliman-Khara, Anna Forsythe

Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice

Renzo Mignani, Elena Biagini, Vittoria Cianci, Federico Pieruzzi, Antonio Pisani, Antonino Tuttolomondo, Maurizio Pieroni

Machine Learning Applications in Acute Coronary Syndrome: Diagnosis, Outcomes and Management

Shanshan Nie, Shan Zhang, Yuhang Zhao, Xun Li, Huaming Xu, Yongxia Wang, Xinlu Wang, Mingjun Zhu

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals

Christoph D. Spinner, Samira Bell, Hermann Einsele, Cécile Tremblay, Michel Goldman, Zain Chagla, Axel Finckh, Christopher J. Edwards, Igor Aurer, Odile Launay, Carolina Casañas i Comabella, Samantha James, Sabada Dube, Katarzyna Borkowska, Fungwe Jah, Walid Kandeil, Renata T. C. Yokota, Cécile Artaud, Jacques-Eric Gottenberg, Loreto Gesualdo, Dominique Bertrand, Sofie Arnetorp, Gkikas Magiorkinis

One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis

Piergiacomo Calzavara-Pinton, Chia-Yu Chu, Hilde Lapeere, Mariateresa Rossi, Silvia M. Ferrucci, Wen-Hung Chung, Anne-Claire Fougerousse, Daria S. Fomina, Gregor Holzer, Jarmila Čelakovská, Mona Al-Ahmad, Thrasyvoulos Tzellos, Jiangming Wu, Marius Ardeleanu, Kwinten Bosman

Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors

Philip J. Mease, Shannon A. Ferrante, Natalie J. Shiff, Timothy P. Fitzgerald, Soumya D. Chakravarty, Jessica A. Walsh

Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review

  • Open Access
  • Lymphoma
  • Original Research

Katharina Büsch, Heidi L. Memmott, Heather M. McLaughlin, Julia E. M. Upton, Amanda Harrington

A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan

Naoto Nakagawa, Runa Ono, Keita Odanaka, Hiroshi Ohara, Shigeki Kisara, Kitae Ito

Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis

Gottfried Rudofsky, Markus Menzen, Louis Potier, Andrei-Mircea Catarig, Alice Clark, Prachi Priyadarshini, Cristina Abreu

Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial

Awadhesh Kumar Singh, Ashok Kumar Das, L. Sreenivasa Murthy, Samit Ghosal, Rakesh Sahay, K. V. S. Harikumar, Ganesh Hosahithlu Keshava, Mayur Agarwal, G. Vijayakumar, Pramila Kalra, Piyush Lodha, Sambit Das, Shehla Shaikh, Soumik Goswami, T. P. Ajish, Prashant Kumthekar, Mihir Upadhyay, Anthuvan Thamburaj, Aushili Mahule, Ashish Prasad, Abhijit Pednekar

Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers

Xiaodong Wang, Rachel Kirk, Mark Matijevic, Minggeng Gao, Allen Poma, Shauna Quinn, Sujata Arora, Tanya Fischer

Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data

Corinne Young, Lydia Y. Lee, Kristi K. DiRocco, Guillaume Germain, Jacob Klimek, François Laliberté, Dominique Lejeune, Stephen G. Noorduyn, Rosirene Paczkowski

Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry

Njira L. Lugogo, Xavier Soler, Yasuhiro Gon, Andréanne Côté, Ole Hilberg, Changming Xia, Yi Zhang, Lucía de Prado Gómez, Paul J. Rowe, Amr Radwan, Juby A. Jacob-Nara, Yamo Deniz, Anju T. Peters

Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United Kingdom

  • Open Access
  • Fatigue
  • Original Research

Jennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, Ashley Valentine, Anthony Mason, Nanxin Li, Zahra Pakbaz, Farrukh Shah, Antony P. Martin

Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis

Jagadeswara R. Earla, Allison W. Kurian, Kalé Kponee-Shovein, Malena Mahendran, Yan Song, Qi Hua, Annalise Hilts, Yezhou Sun, Kim M. Hirshfield, Mark Robson, Jaime A. Mejia

Healthcare Utilization, Costs, and Treatment Discontinuation in Adults with Episodic Migraine Initiating Galcanezumab Versus Rimegepant: A US Retrospective Claims Analysis

Gilwan Kim, Margaret Hoyt, Armen Zakharyan, Jennifer Durica, Alexandra Wallem, Lars Viktrup

Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung Disease

  • Open Access
  • Fatigue
  • Original Research

Kelly P. McCarrier, Mariam Hassan, Dayton W. Yuen, Jui-Hua Tsai, Nancy Touba, Kevin C. Mange

An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma

Kerigo Ndirangu, Abby Paine, Hollie Pilkington, David Trueman

Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective

Ataru Igarashi, Kenichi Ohara, Hiroyuki Matsuda, Junko Morii, Suchitra Jagannathan, Ronald Filomeno

Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2–4 Years with Rett Syndrome

Mona Darwish, Julie Passarell, Kelly Maxwell, Heather Bradley, Kathie M. Bishop, James M. Youakim

Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett Syndrome

Mona Darwish, Julie Passarell, Kelly Maxwell, James M. Youakim, Heather Bradley, Kathie M. Bishop

The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn’s Disease

Marla Dubinsky, Aisha Vadhariya, Sylvia Su, Xian Zhou, Frederick Durand, Claudine Clucas, Larissa Stassek, Ariane K. Kawata, Simon Travis

Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)

Alan P. Baptist, Guillaume Germain, Jacob Klimek, François Laliberté, Robert C. Schell, Sergio Forero-Schwanhaeuser, Alison Moore, Stephen G. Noorduyn, Rosirene Paczkowski

Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan

Yoshikazu Inoue, Takashi Ogura, Arata Azuma, Yasuhiro Kondoh, Sakae Homma, Kenya Muraishi, Rie Ikeda, Kaori Ochiai, Yukihiko Sugiyama, Toshihiro Nukiwa

Clinical Features and Current Pharmacotherapy of OAB in Practice: Ideal and Reality

Kazuna Tsubouchi, Hisatomi Arima, Taiki Emoto, Hiroshi Nakazawa, Takahiro Kitano, Masashi Mikami, Chikao Aoyagi, Hiroshi Matsuzaki, Kosuke Tominaga, Naotaka Gunge, Takeshi Miyazaki, Yu Okabe, Nobuyuki Nakamura, Yuichiro Fukuhara, Masahiro Tachibana, Chizuru Nakagawa, Fumihiro Yamazaki, Nobuhiro Haga

Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice

Stella S. Daskalopoulou, Helena Papacostas-Quintanilla, Romualda Brzozowska-Villatte

Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease

David Mannino, Stephen Weng, Guillaume Germain, Julien Boudreau, Anabelle Tardif-Samson, Sergio Forero-Schwanhaeuser, François Laliberté, Patrick Gravelle, Chris H. Compton, Stephen G. Noorduyn, Rosirene Paczkowski

Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies

Risa Kagan, Antonio Cano, Rossella E. Nappi, Marci L. English, Shayna Mancuso, Xi Wu, Faith D. Ottery

US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review

Patrick Eugeni, Megan E. Rooney, Nicolas P. Saikali, Zhongzheng Niu, Maurice T. Driessen, Lynda J. Krasenbaum, Karen Carr, Michael J. Seminerio, Jennifer W. McVige

Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study

Ka-On Lam, Karen Hoi-Lam Li, Roland Ching-Yu Leung, Vikki Tang, Thomas Yau

Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19

  • Open Access
  • COVID-19
  • Original Research

Michael Dreher, Hanna-Teresa Heier, Andrea Kienle-Gogolok, Kristina Röschmann-Doose, Jörg Simon, Ravi Singhal, Heidrun Täschner, Jörn Thomsen, Joachim Weimer, Thomas Wittig, Otto Wonhas, Manuela Thinesse-Mallwitz

Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia

Pengxiang Li, Zhi Geng, Carmela Benson, Charmi Patel, Jalpa A. Doshi

Assessment of the Potential Clinical and Economic Impact of Weight Loss in the Adult Population with Obesity and Associated Comorbidities in Spain

  • Open Access
  • Obesity
  • Original Research

María Dolores Ballesteros-Pomar, Ened Rodríguez-Urgellés, Miquel Sastre-Belío, Alberto Martín-Lorenzo, Volker Schnecke, Lluís Segú, Max Brosa, Nuria Vilarrasa

CKD-Associated Pruritus is Associated with Greater Use of Antidepressants and Anti-pruritus Medications

Jasmine Ion Titapiccolo, Luca Neri, Thilo Schaufler, Hans-Jurgen Arens, Len Usvyat, Stefano Stuard, Marco Soro

Correction to: Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years

Mauricio Torres Pradilla, Erick Álvarez, Mónica Novoa, Ivonne Lozano, Maribel Trujillo

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more